Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Undiagnosed impaired fasting glucose and diabetes mellitus amongst inpatients receiving antipsychotic drugs.

Taylor D, Young C, Mohamed R, Paton C, Walwyn R.

J Psychopharmacol. 2005 Mar;19(2):182-6.

PMID:
15728440
2.

Prediabetic increase in hemoglobin A1c compared with impaired fasting glucose in patients receiving antipsychotic drugs.

Manu P, Correll CU, Wampers M, van Winkel R, Yu W, Mitchell AJ, De Hert M.

Eur Neuropsychopharmacol. 2013 Mar;23(3):205-11. doi: 10.1016/j.euroneuro.2012.05.002. Epub 2012 May 29.

PMID:
22652493
3.

Prevalence of diabetes mellitus among outpatients with severe mental disorders receiving atypical antipsychotic drugs.

Lamberti JS, Crilly JF, Maharaj K, Olson D, Wiener K, Dvorin S, Costea GO, Bushey MP, Dietz MB.

J Clin Psychiatry. 2004 May;65(5):702-6.

PMID:
15163259
4.

Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment.

Cohen D, Dekker JJ, Peen J, Gispen-de Wied CC.

Eur Neuropsychopharmacol. 2006 Apr;16(3):187-94. Epub 2005 Nov 2.

PMID:
16263247
5.

Incident diabetes associated with antipsychotic use in the United Kingdom general practice research database.

Kornegay CJ, Vasilakis-Scaramozza C, Jick H.

J Clin Psychiatry. 2002 Sep;63(9):758-62.

PMID:
12363114
6.

Atypical antipsychotics and glucose homeostasis.

Bergman RN, Ader M.

J Clin Psychiatry. 2005 Apr;66(4):504-14. Review.

PMID:
15816794
7.

Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates.

Lamberti JS, Costea GO, Olson D, Crilly JF, Maharaj K, Tu X, Groman A, Dietz MB, Bushey MP, Olivares T, Wiener K.

J Clin Psychiatry. 2005 Jul;66(7):900-6.

PMID:
16013906
8.

Effect of age, family history of diabetes, and antipsychotic drug treatment on risk of diabetes in people with psychosis: a population-based cross-sectional study.

Foley DL, Mackinnon A, Morgan VA, Watts GF, Castle DJ, Waterreus A, Galletly CA.

Lancet Psychiatry. 2015 Dec;2(12):1092-8. doi: 10.1016/S2215-0366(15)00276-X. Epub 2015 Oct 22.

PMID:
26477242
9.

Testing for diabetes in hospitalised patients prescribed antipsychotic drugs.

Taylor D, Young C, Esop R, Paton C, Walwyn R.

Br J Psychiatry. 2004 Aug;185:152-6.

10.

Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders.

Cohen D, Stolk RP, Grobbee DE, Gispen-de Wied CC.

Diabetes Care. 2006 Apr;29(4):786-91.

PMID:
16567816
12.

The relationship of hepatitis antibodies and elevated liver enzymes with impaired fasting glucose and undiagnosed diabetes.

Mainous AG 3rd, Diaz VA, King DE, Everett CJ, Player MS.

J Am Board Fam Med. 2008 Nov-Dec;21(6):497-503. doi: 10.3122/jabfm.2008.06.080047. Erratum in: J Am Board Fam Med. 2009 Mar-Apr;22(2):229.

13.

The prevalence and clinical-demographic correlates of diabetes mellitus in chronic schizophrenic patients receiving clozapine.

Zhang R, Hao W, Pan M, Wang C, Zhang X, Chen DC, Xiu MH, Yang FD, Kosten TR, Zhang XY.

Hum Psychopharmacol. 2011 Aug;26(6):392-6. doi: 10.1002/hup.1220. Epub 2011 Aug 8.

PMID:
21826737
14.

The burden of diabetes mellitus and impaired fasting glucose in an urban population of Sri Lanka.

Pinidiyapathirage MJ, Kasturiratne A, Ranawaka UK, Gunasekara D, Wijekoon N, Medagoda K, Perera S, Takeuchi F, Kato N, Warnakulasuriya T, Wickremasinghe AR.

Diabet Med. 2013 Mar;30(3):326-32. doi: 10.1111/dme.12013.

15.

Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.

Østbye T, Curtis LH, Masselink LE, Hutchison S, Wright A, Dans PE, Schulman KA, Krishnan RR.

Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):407-15.

PMID:
15372671
16.

Assessment of monitoring for glucose and lipid dysregulation in adult Medi-Cal patients newly started on antipsychotics.

Barnett M, VonMuenster S, Wehring H, Popish S, McDonald K, Walker VM, Perry P.

Ann Clin Psychiatry. 2010 Feb;22(1):9-18.

PMID:
20196978
17.

Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs.

Morrato EH, Druss B, Hartung DM, Valuck RJ, Allen R, Campagna E, Newcomer JW.

Arch Gen Psychiatry. 2010 Jan;67(1):17-24. doi: 10.1001/archgenpsychiatry.2009.179.

PMID:
20048219
18.

Diabetes mellitus in genetically isolated populations in Jordan: prevalence, awareness, glycemic control, and associated factors.

Dajani R, Khader YS, Fatahallah R, El-Khateeb M, Shiyab AH, Hakooz N.

J Diabetes Complications. 2012 May-Jun;26(3):175-80. doi: 10.1016/j.jdiacomp.2012.03.009. Epub 2012 Apr 12.

PMID:
22502937
19.

Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics.

Henderson DC, Cagliero E, Copeland PM, Louie PM, Borba CP, Fan X, Freudenreich O, Goff DC.

J Clin Psychiatry. 2007 Apr;68(4):533-41.

PMID:
17474808
20.

Prevalence of prediabetes and newly diagnosed diabetes in patients with a transient ischemic attack or stroke.

Fonville S, Zandbergen AA, Vermeer SE, Dippel DW, Koudstaal PJ, den Hertog HM.

Cerebrovasc Dis. 2013;36(4):283-9. doi: 10.1159/000353677. Epub 2013 Oct 16.

PMID:
24135458

Supplemental Content

Support Center